Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Sell
34,050
-16,000
-32% -$1.12M 0.15% 81
2026
Q1
$3.78M Buy
50,050
+16,000
+47% +$1.14M 0.54% 41
2025
Q4
$2.1M Sell
34,050
-700
-2% -$41.2K 0.28% 68
2025
Q3
$2.04M Sell
34,750
-7,000
-17% -$408K 0.29% 69
2025
Q2
$2.43M Buy
41,750
+6,200
+17% +$350K 0.38% 48
2025
Q1
$1.77M Buy
35,550
+11,990
+51% +$613K 0.34% 63
2024
Q4
$1.52M Buy
+23,560
New +$1.12M 0.27% 72

Other funds holding NTR

Sava Infond's NTR Position: Q2 2026 in Review

Sava Infond reduced its Nutrien (NTR) stake by 32% in Q2 2026, selling an estimated $1.12M and leaving 34,050 shares worth $2.14M. The position accounts for 0.15% of the portfolio, ranked #81.

Sava Infond first reported a position in NTR in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.78M in Q1 2026. 105 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Sava Infond held 34,050 shares of Nutrien worth $2.14M as of Q2 2026.
  • Sava Infond sold 16,000 Nutrien shares in Q2 2026, an estimated $1.12M.
  • Nutrien made up 0.15% of Sava Infond's portfolio in Q2 2026, its #81 holding.
  • Sava Infond first reported a position in Nutrien in Q4 2024 and has held it in 7 quarters since.
  • Sava Infond's Nutrien position peaked at $3.78M in Q1 2026.
  • 105 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.